These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 63040)

  • 1. Influence of somatostatin on carbohydrate disposal and absorption in diabetes mellitus.
    Wahren J
    Lancet; 1976 Dec; 2(7997):1213-6. PubMed ID: 63040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biphasic effect of somatostatin on oral glucose tolerance in maturity-onset diabetes.
    Tamborlane WV; Sherwin RS; Hendler R; Felig P
    Metabolism; 1978 Jul; 27(7):849-53. PubMed ID: 661568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal pancreatic glucagon secretion and postprandial hyperglycemia in diabetes mellitus.
    Gerich JE; Lorenzi M; Karam JH; Schneider V; Forsham PH
    JAMA; 1975 Oct; 234(2):159-5. PubMed ID: 1242153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidiabetic action of somatostatin after oral glucose loading: due to suppression of glucagon and growth hormone or of intestinal carbohydrate absorption?
    Bratusch-Marrain P; Vierhapper H; Grubeck-Loebenstein B; Waldhäusl W; Nowotny P
    Horm Metab Res; 1981 Jun; 13(6):305-9. PubMed ID: 6114914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin, glucagon, and somatostatin in normal physiology and diabetes mellitus.
    Felig P; Wahren J; Sherwin R; Hendler R
    Diabetes; 1976 Dec; 25(12):1091-9. PubMed ID: 992227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of somatostatin added to insulin in a glucose-controlled insulin infusion system.
    Selam JL; Chenon D; Pham TC; Gagnol JP; Sany C; Thomas N; Gravagne G; Orsetti A; Mirouze J
    Diabetologia; 1981 Aug; 21(2):126-30. PubMed ID: 6114891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a long-acting somatostatin analogue on postprandial hyperglycemia in insulin-dependent diabetes mellitus.
    Dimitriadis G; Tessari P; Gerich J
    Metabolism; 1983 Oct; 32(10):987-92. PubMed ID: 6136893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose homeostasis during prolonged suppression of glucagon and insulin secretion by somatostatin.
    Sherwin RS; Hendler R; DeFronzo R; Wahren J; Felic P
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):348-52. PubMed ID: 264686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. alpha-Glucosidase inhibition improves postprandial hyperglycemia and decreases insulin requirements in insulin-dependent diabetes mellitus.
    Dimitriadis GD; Tessari P; Go VL; Gerich JE
    Metabolism; 1985 Mar; 34(3):261-5. PubMed ID: 3883097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of somatostatin as a potential ajunct to insulin in the management of diabetes mellitus.
    Gerich JE; Schultz TA; Lewis SB; Karam JH
    Diabetologia; 1977 Sep; 13(5):537-44. PubMed ID: 908478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of insulin on splanchnic and peripheral glucose disposal after an intravenous glucose load in man.
    Saccà L; Cicala M; Trimarco B; Ungaro B; Vigorito C
    J Clin Invest; 1982 Jul; 70(1):117-26. PubMed ID: 6123524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a new long-acting somatostatin analogue (SMS 201-995) on glycemic and hormonal response to a mixed meal in acromegalic patients.
    Candrina R; Gussago A; Giustina G
    J Endocrinol Invest; 1988 Jan; 11(1):21-6. PubMed ID: 2896207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased intestinal glucose absorption and postprandial hyperglycaemia at the early step of glucose intolerance in Otsuka Long-Evans Tokushima Fatty rats.
    Fujita Y; Kojima H; Hidaka H; Fujimiya M; Kashiwagi A; Kikkawa R
    Diabetologia; 1998 Dec; 41(12):1459-66. PubMed ID: 9867213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic effects of somatostatin in maturity-onset diabetes.
    Tamborlane WV; Sherwin RS; Hendler R; Felig P
    N Engl J Med; 1977 Jul; 297(4):181-3. PubMed ID: 876274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of glucagon on postprandial carbohydrate metabolism in nondiabetic humans.
    Frank JW; Camilleri M; Thomforde GM; Dinneen SF; Rizza RA
    Metabolism; 1998 Jan; 47(1):7-12. PubMed ID: 9440470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM.
    Dinneen S; Alzaid A; Turk D; Rizza R
    Diabetologia; 1995 Mar; 38(3):337-43. PubMed ID: 7758881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [ Somatostatin in insulin-dependent diabetics and in pancreatectomized patients (author's transl)].
    Tragl KH; Pointner H; Kinast H; Flegel U; Deutsch E
    Wien Klin Wochenschr; 1976 Sep; 88(16):530-2. PubMed ID: 1033640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibitory effect of somatostatin on growth hormone, insulin and glucagon secretion in diabetes mellitus.
    Ward FR; Leblanc H; Yen SS
    J Clin Endocrinol Metab; 1975 Sep; 41(3):527-32. PubMed ID: 1159060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.
    Gerich JE; Lorenzi M; Bier DM; Tsalikian E; Schneider V; Karam JH; Forsham PH
    J Clin Invest; 1976 Apr; 57(4):875-84. PubMed ID: 820717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose, insulin and somatostatin infusion for the determination of insulin sensitivity.
    Harano Y; Ohgaku S; Hidaka H; Haneda K; Kikkawa R; Shigeta Y; Abe H
    J Clin Endocrinol Metab; 1977 Nov; 45(5):1124-7. PubMed ID: 925138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.